Dr. Dmitriy Zamarin, MD
Claim this profileMemorial Sloan Kettering Cancer Center
Studies Ovarian Cancer
Studies Endometrial Cancer
5 reported clinical trials
11 drugs studied
Area of expertise
1Ovarian Cancer
Stage III
Stage IV
2Endometrial Cancer
Stage III
Stage IV
MLH1 positive
Affiliated Hospitals
Clinical Trials Dmitriy Zamarin, MD is currently running
STK-012 + Pembrolizumab
for Cancer
This trial is testing a new drug called STK-012 alone and with another medication in patients with advanced solid tumors that haven't responded to usual treatments. The aim is to find the right dose and see how well it works.
Recruiting1 award Phase 13 criteria
Radiation + Dostarlimab
for Endometrial Cancer
This trial is testing if combining radiation and Dostarlimab can effectively treat women with a specific type of endometrial cancer after surgery.
Recruiting2 awards Phase 2
More about Dmitriy Zamarin, MD
Clinical Trial Related3 years of experience running clinical trials · Led 5 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Dmitriy Zamarin, MD has experience with
- Pembrolizumab
- ELU001
- STK-012
- Brachytherapy
- External Beam Radiation Therapy
- Carboplatin
Breakdown of trials Dmitriy Zamarin, MD has run
Ovarian Cancer
Endometrial Cancer
Uterine Cancer
Endometrial Adenocarcinoma
Ovarian Disease
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Dmitriy Zamarin, MD specialize in?
Dmitriy Zamarin, MD focuses on Ovarian Cancer and Endometrial Cancer. In particular, much of their work with Ovarian Cancer has involved Stage III patients, or patients who are Stage IV.
Is Dmitriy Zamarin, MD currently recruiting for clinical trials?
Yes, Dmitriy Zamarin, MD is currently recruiting for 2 clinical trials in New York New York. If you're interested in participating, you should apply.
Are there any treatments that Dmitriy Zamarin, MD has studied deeply?
Yes, Dmitriy Zamarin, MD has studied treatments such as Pembrolizumab, ELU001, STK-012.
What is the best way to schedule an appointment with Dmitriy Zamarin, MD?
Apply for one of the trials that Dmitriy Zamarin, MD is conducting.
What is the office address of Dmitriy Zamarin, MD?
The office of Dmitriy Zamarin, MD is located at: Memorial Sloan Kettering Cancer Center, New York, New York 10065 United States. This is the address for their practice at the Memorial Sloan Kettering Cancer Center.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.